Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Catheter Ablation for Arrhythmias in CRT Non-Responders
NCT03035227Phase 4Terminated
- Sponsor
- Kansas City Heart Rhythm Institute
- Start
- Jan 2017
- Primary completion
- May 2018
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in arrhythmia and heart failure (HF), sponsored by Kansas City Heart Rhythm Institute. Primary endpoints: Ejection Fraction at 90 days, Bi-ventricular Pacing Improvement at 90 days and 1 more. Started Jan 2017; status: terminated.
02
Conditions
arrhythmiaheart failure (HF)
Beyond the preview
Go deeper on NCT03035227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03035227.